ZnO Nanoparticles Modified with an Amphipathic Peptide Show Improved Photoprotection in Skin.
Anusha AdityaSabyasachi ChattopadhyayNidhi GuptaShamshad AlamArchana Palillam VeeduMrinmoy PalArchana SinghDeenan SanthiyaKausar Mahmood AnsariMunia GanguliPublished in: ACS applied materials & interfaces (2018)
ZnO nanoparticles of different sizes were functionalized with an amphipathic peptide, and its effect on nanoparticle stabilization and UV photoprotective activity was studied in this article. The peptide-modified nanoparticles exhibited lower aggregation, significant reduction in Zn2+ leaching in vitro and even inside the cells for smaller particle sizes, reduced photocatalytic activity, and reduced cellular toxicity under UV-B treated conditions. In addition, the peptide-modified 60 nm ZnO nanoparticles showed lower genotoxicity, lower oxidative stress induction levels, less DNA damage responses, and less immunogenic potential than the bare counterparts in the presence of UV-B rays. They localized more in the stratum corneum and epidermis ex vivo, indicating better retention in epidermis, and demonstrated improved UV-B protection and/or skin integrity in SKH-1 mice in vivo compared to unmodified nanoparticles and commercial UV-protective agents tested. To our knowledge, this is the first report on the application of peptide-modified ZnO nanoparticles for improved photoprotection.
Keyphrases
- oxidative stress
- dna damage
- quantum dots
- room temperature
- reduced graphene oxide
- visible light
- induced apoptosis
- heavy metals
- healthcare
- walled carbon nanotubes
- gold nanoparticles
- dna repair
- wound healing
- ischemia reperfusion injury
- mass spectrometry
- insulin resistance
- metabolic syndrome
- light emitting
- diabetic rats
- high resolution
- aqueous solution
- cell cycle arrest
- liquid chromatography